Results 131 to 140 of about 133,355 (312)

How to achieve balloon stability in aortic valvuloplasty using rapid ventricular pacing [PDF]

open access: yes, 2004
Balloon aortic valvuloplasty is now the treatment of choice for congenital aortic stenosis. Balloon stability may be difficult to achieve and this may result in a suboptimal result or even valve damage.
Shebani, S.   +3 more
core  

How much of the intraaortic balloon volume is displaced toward the coronary circulation?

open access: yes, 2010
This is a post-print version of the published article. Copyright @ 2010 The American Association for Thoracic Surgery.This article has been made available through the Brunel Open Access Publishing Fund.Objective: During intraaortic balloon inflation ...
Pantalos, GM   +7 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

Quadricuspid aortic valve: a rare cause of aortic regurgitation and stenosis

open access: yesThe Turkish Journal of Pediatrics, 2008
Quadricuspid aortic valve is a rare congenital condition that occurs not only as an isolated anomaly, but also with other cardiac defects. We describe a 10-year-old boy whose aortic stenosis was diagnosed during infancy.
Selman Vefa Yildirim   +3 more
doaj  

One-stop transcatheter aortic valve replacement and fenestrated endovascular aortic aneurysm repair: A case report

open access: yesRadiology Case Reports
The management of patients with severe aortic valve stenosis and an abdominal aortic aneurysm is a real therapeutic challenge. Minimally invasive treatment is more beneficial than open surgery for treating both aortic valve stenosis and abdominal aortic ...
Abderrahim Sanoussi, MD   +2 more
doaj   +1 more source

Early Outcomes of Aortic Valve Bicuspidization Using Autologous Pericardium in Pediatric Aortic Stenosis: a Preliminary Case Series [PDF]

open access: yes
Aortic valve bicuspidization using autologous pericardium is a promising valve-sparing technique for treating aortic stenosis in pediatric patients. However, literature describing this procedure in children remains limited.
Akkerbez Adilbekova   +6 more
core   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Clinical Conundrum: Lifetime Management of Aortic Stenosis in Young Patients [PDF]

open access: yes
The management of aortic stenosis (AS) in younger patients presents significant clinical challenges. While transcatheter aortic valve replacement (TAVR) offers a minimally invasive approach with favourable short- and mid-term outcomes, its long-term ...
Konstantinos Toutouzas   +3 more
core   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy